Table 3.
Pathological stage | |||
---|---|---|---|
pT2 | pT3a | pT3b | |
N | 74 | 48 | 11 |
No. with PSM | 19 (26 %) | 22 (46 %) | 8 (73 %) |
CCO evidentiary base | 0 – 24% | 24.2 – 64.3% | 27.1 – 80% |
RP: radical prostatectomy; PSM: positive surgical margin; CCO: Cancer Care Ontario.
Pathological stage | |||
---|---|---|---|
pT2 | pT3a | pT3b | |
N | 74 | 48 | 11 |
No. with PSM | 19 (26 %) | 22 (46 %) | 8 (73 %) |
CCO evidentiary base | 0 – 24% | 24.2 – 64.3% | 27.1 – 80% |
RP: radical prostatectomy; PSM: positive surgical margin; CCO: Cancer Care Ontario.